COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,761 Articles (22,502 medRxiv, 8,259 bioRxiv)

Most recent first Previous |  Page 2229: Articles 22281-22290  | Next

Is climate a curse or a bless in the Covid-19 virus fighting?
DAMETTE, O., Mathonnat, C., Goutte, S.
10.1101/2020.09.04.20182998 — Posted: 2020-09-07
CAN EDUCATIONAL INSTITUTIONS REOPEN FOR IN-PERSON CLASSES SAFELY AMID THE COVID-19 PANDEMIC?
Mukherjee, U. K., Bose, S., Ivanov, A., Souyris, S., Seshadri, S., Sridhar, P., Watkins, R., Yu, Y.
10.1101/2020.09.04.20188680 — Posted: 2020-09-07
COVID-19 superspreading in cities versus the countryside
Eilersen, A., Sneppen, K.
10.1101/2020.09.04.20188359 — Posted: 2020-09-07
Variations in state-level SARS-COV-2 testing recommendations in the United States, March-July 2020
Perniciaro, S. R., Weinberger, D. M.
10.1101/2020.09.04.20188326 — Posted: 2020-09-07
Modeling COVID-19 dynamics in the sixteen West African countries
Honfo, S. H., Taboe, B. H., Glele Kakai, R.
10.1101/2020.09.04.20188532 — Posted: 2020-09-07
Serological Responses to Human Virome Define Clinical Outcomes of Italian Patients Infected with SARS-CoV-2
Wang, L., Candia, J., Ma, L., Zhao, Y., Imberti, L., Sottini, A., Dobbs, K., NIAID-NCI COVID Consortium, , Lisco, A., Sereti, I., Su, H. C., Notarangelo, L. D., Wang, X. W.
10.1101/2020.09.04.20187088 — Posted: 2020-09-07
Health professionals practice and associated factors towards precautionary measures for COVID-19 pandemic in public health facilities of Gamo zone, southern Ethiopia: a cross-sectional study
Mersha, A., Shibiru, S., Girma, M., Ayele, G., Bante, A., Kassa, M., Abebe, S., Shewangizaw, M.
10.1101/2020.09.05.20188805 — Posted: 2020-09-07
COVID-19 Preprints and Their Publishing Rate: An Improved Method
Lachapelle, F.
10.1101/2020.09.04.20188771 — Posted: 2020-09-07 Discussion: Offsite
Trans-ethnic analysis reveals genetic and non-genetic associations with COVID-19 susceptibility and severity
Shelton, J. F., Shastri, A. J., Ye, C., Weldon, C. H., Filshtein-Somnez, T., Coker, D., Symons, A., Esparza-Gordillo, J., The 23andMe COVID-19 Team, , Aslibekyan, S., Auton, A.
10.1101/2020.09.04.20188318 — Posted: 2020-09-07 Discussion: Onsite
Contact tracing efficiency, transmission heterogeneity, and accelerating COVID-19 epidemics
Gardner, B., Kilpatrick, A. M.
10.1101/2020.09.04.20188631 — Posted: 2020-09-07 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).